Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT04888468 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Relapsed Pediatric ALL
Refractory Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: pCAR-19B cells

Sponsor

Chongqing Precision Biotech Co., Ltd